If you are wondering whether UiPath's current share price really reflects what the business is worth, you are not alone. This article is going to focus squarely on that question. UiPath shares last ...

UiPath Chief Marketing Officer Michael Atalla argues that enterprises aren’t moving toward agent-only automation, but toward ...

Investors should look at these three options as swing-for-the-fences stock picks.

UiPath's fair value estimate has ticked higher from about $13.86 to $15.93 per share, even as analysts keep a neutral stance on the stock. Behind this shift are slightly higher required returns of ...

UiPath hits an inflection point with stabilizing SaaS, AI roadmap, Maestro platform upsells, top partnerships, and clean ...

UiPath faces significant challenges, and its stock price reflects them. Leadership changes and solid financial metrics could pave the way to a recovery. The stock price is down 54% from recent highs, ...

UiPath stock surged more than 40% this week following a new collaboration with ChatGPT maker OpenAI on agentic AI technology. The rally actually started last week when UiPath announced integrations ...

Robotic process automation (RPA) tools are paving the way for greater productivity, more precision, and accelerated digital transformation for businesses across all industries. There are many tools on ...

UiPath's share price has risen in recent months despite ongoing losses and slow growth. While market conditions are stable, there is still elevated deal scrutiny and longer sales cycles, particularly ...

Back in early 2021, it seemed everything was going right for UiPath. At a time when there were a number of high-flying enterprise startups, UiPath was at the top of the heap when it raised $750 ...

Shares of UiPath Inc. (NYSE: PATH) have been on a tear, grabbing fresh attention after the company posted better-than-expected fiscal year 2026 (FY 2026) Q3 earnings and broke out to new 52-week highs ...

The latest price target for UiPath (NYSE:PATH) was reported by Barclays on January 12, 2026. The analyst firm set a price target for $18.00 expecting PATH to rise to within 12 months (a possible 12.99 ...